13F Data
Security · CUSIP 03753UAB2

APELLIS PHARMACEUTICALS INC

NOTE 3.500% 9/1 · institutional ownership from 13F filings
13F holders
0
Shares held
0
Value held
$0
New / sold out
0 / 1
Added / reduced
0 / 0
net -1.1M shares

13F holders by quarter

Q3 2020: 4Q4 2020: 7Q1 2021: 6Q2 2021: 7Q3 2021: 4Q4 2021: 4Q1 2022: 2Q2 2022: 1Q3 2022: 2Q4 2022: 2Q1 2023: 2Q2 2023: 2Q3 2023: 1Q4 2023: 1Q1 2024: 3Q2 2024: 1Q3 2024: 1Q4 2024: 1Q1 2025: 1Q2 2025: 1Q1 2026: 1Q2 2026: 0
Q3 2020Q2 2026

Net shares bought by existing holders

Q3 2020: 21.4MQ4 2020: 58.4MQ1 2021: -70.0MQ2 2021: 6.3MQ3 2021: -15.9MQ4 2021: -79.0KQ1 2022: -131.0KQ2 2022: -66.0KQ3 2022: 1.2MQ4 2022: 3.6MQ1 2023: 4.8MQ2 2023: 2.1MQ3 2023: -11.7MQ4 2023: 0Q1 2024: 6.0MQ2 2024: -6.0MQ3 2024: 0Q4 2024: 0Q1 2025: 0Q2 2025: 0Q1 2026: 1.1MQ2 2026: -1.1M
Q3 2020Q2 2026

Top holders · Q2 2026

Nothing to show.

Biggest buyers

Nothing to show.

Biggest sellers

ManagerChangeShares changeChange %
CANTOR FITZGERALD, L. P.Sold out-1,130,000-100.0%